Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

NeoPharm, FDA Define Plans For IL13's Phase III Program

Feb. 9, 2004

By Aaron Lorenzo

Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline

Feb. 6, 2004

By Aaron Lorenzo

Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline

Feb. 6, 2004

By Aaron Lorenzo

Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott

Feb. 5, 2004

By Aaron Lorenzo

Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott

Feb. 5, 2004

By Aaron Lorenzo

Liver Drug Developer Metabasis Files Registration For $86M IPO

Feb. 4, 2004

By Aaron Lorenzo

Liver Drug Developer Metabasis Files Registration For $86M IPO

Feb. 4, 2004

By Aaron Lorenzo

Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering

Feb. 3, 2004

By Aaron Lorenzo

Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering

Feb. 3, 2004

By Aaron Lorenzo

Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale

Feb. 2, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...